Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China · Delayed Price · Currency is CNY 20.27
+0.50 (2.53%)
At close: Mar 6, 2026
Nanjing Vazyme Biotech Market Cap
Nanjing Vazyme Biotech has a market cap or net worth of 8.06 billion as of March 6, 2026. Its market cap has decreased by -2.92% in one year.
Market Cap
8.06B
Enterprise Value
6.20B
Revenue
1.38B
Ranking
n/a
PE Ratio
n/a
Stock Price
20.27
Market Cap Chart
Since November 15, 2021, Nanjing Vazyme Biotech's market cap has decreased from 34.14B to 8.06B, a decrease of -76.39%. That is a compound annual growth rate of -28.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 8.06B | 1.25% |
| Dec 31, 2025 | 7.96B | -9.63% |
| Dec 31, 2024 | 8.81B | -31.21% |
| Dec 29, 2023 | 12.81B | -39.74% |
| Dec 30, 2022 | 21.26B | -49.87% |
| Dec 31, 2021 | 42.40B | 24.19% |
| Nov 15, 2021 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sino Biological,Inc. | 8.42B |
| Daan Gene | 8.31B |
| Jiangxi Fushine Pharmaceutical | 8.22B |
| Chengdu Kanghua Biological Products | 7.97B |
| Youcare Pharmaceutical Group | 7.93B |
| Anhui Huaheng Biotechnology | 7.88B |
| Suzhou Fengbei Biotech Stock | 7.83B |
| Zhejiang Ausun Pharmaceutical | 7.64B |